Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly. Staying updated with the latest advancements in cancer care has never been easier. Join experts to explore cutting-edge insights into sarcoma and rare cancers: multidisciplinary care, molecular diagnostics, precision therapies, and research advancements to improve patient outcomes.
We published three new titles last year: Breast Cancer, Gynaecological Tumours and Lymphomas - all written with young oncologists in mind. Join us in Vienna, or online, for a comprehensive exploration of the latest clinical and research developments in gynaecological malignancies. New indication concerns monotherapy as part of consolidation therapy for the treatment of adult patients with newly diagnosed Philadelphia chromosome-negative CDpositive B-cell precursor ALL.
Leading experts will present and discuss the research advancements in the rapidly evolving field of immuno-oncology. The Molecular Analysis for Precision Oncology Congress MAP is the appointment where globally recognised experts will present and discuss research in precision medicine, technologies for cancer profiling, mechanisms driving tumour expansion, metastatic dissemination, clonal evolution, and biomarker-driven development of targeted therapeutics.
The ESMO Congress taking place September in Barcelona, Spain, offers a comprehensive view of the current drug development landscape, with existing medicines demonstrating benefit in additional applications and new agents emerging in large numbers as the range of potential molecular targets for therapy continues to expand. According to two international studies presented at the ESMO Congress , women who breastfeed after receiving treatment for breast cancer, including those with a germline BRCA mutation an inherited change in BRCA genes that significantly increases the risk of developing certain cancers, especially breast cancer , do not face an increased risk of recurrence or developing new breast cancers.
Schumacher in recognition of his exceptional contributions to cancer immunology and to our understanding of the mechanism of how immunotherapy works. Bringing another annual reunion of the global oncology community to a resounding close, the 34, attendees of the ESMO Congress had the opportunity to gather around to listen to the most important results presented in different tumour types and research areas.
